Inside Providence plan 340B rebate disruption details the system’s financial and operational readiness for the new federal rebate pilot program.

Oklahoma stepped in to save hospital profits with a new law, but a federal judge put it on hold while drugmakers argue its ...

Guideline Supports Consistent Application of GS1 Standards to Improve Data Accuracy and Visibility in the Healthcare Supply Chain ...

For more than 30 years, thanks to bipartisan congressional support, the 340B program has helped eligible hospitals stretch limited federal resources to reduce the price of outpatient pharmaceuticals ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Nonprofit hospitals and health clinics are alarmed about a change that's coming to federal drug purchasing discounts next ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating facilities.

Key trends pharmacy executives shared at Becker’s 2025 Fall CPO Summit highlight pharmacy’s evolving strategic role in health systems.

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Oklahoma Attorney General fights against a federal injunction blocking state law supporting 340B Drug Pricing for rural ...